Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity(English)

• a program designed to investigate the clinical usefulness of the long-acting angiotensin II type 1 receptor blocker, candesartan cilexetil, in a broad spectrum of patients with symptomatic heart failure
• ACE, CHF, HF, LVEF, EF
• Cardiology, Therapeutic approaches
• https://doi.org…9164(99)90013-1